-
Abbink P, Larocca RA, Visitsunthorn K, Boyd M, De La Barrera RA, Gromowski GD, Kirilova M, Peterson R, Li Z, Nanayakkara O, Nityanandam R, Mercado NB, Borducchi EN, Chandrashekar A, Jetton D, Mojta S, Gandhi P, LeSuer J, Khatiwada S, Lewis MG, Modjarrad K, Jarman RG, Eckels KH, Thomas SJ, Michael NL, Barouch DH, 2017: Durability and correlates of vaccine protection against zika virus in rhesus monkeys[J]. Sci Transl Med, 9, eaao4163-. doi: 10.1126/scitranslmed.aao4163
-
Aliota MT, Caine EA, Walker EC, Larkin KE, Camacho E, Osorio JE, 2016: Characterization of lethal zika virus infection in ag129 mice[J]. PLoS Negl Trop Dis, 10, e0004682-. doi: 10.1371/journal.pntd.0004682
-
Bai B, Lu X, Meng J, Hu Q, Mao P, Lu B, Chen Z, Yuan Z, Wang H, 2008: Vaccination of mice with recombinant baculovirus expressing spike or nucleocapsid protein of sars-like coronavirus generates humoral and cellular immune responses[J]. Mol Immunol, 45, 868-875. doi: 10.1016/j.molimm.2007.08.010
-
Baxter R, Patriarca PA, Ensor K, Izikson R, Goldenthal KL, Cox MM, 2011: Evaluation of the safety, reactogenicity and immunogenicity of flublokⓇ trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50-64 years of age[J]. Vaccine, 29, 2272-2278. doi: 10.1016/j.vaccine.2011.01.039
-
Bogoch Ⅱ, Brady OJ, Kraemer MUG, German M, Creatore MI, Brent S, Watts AG, Hay SI, Kulkarni MA, Brownstein JS, Khan K, 2016: Potential for zika virus introduction and transmission in resource-limited countries in Africa and the Asia-pacific region: a modelling study[J]. Lancet Infect Dis, 16, 1237-1245. doi: 10.1016/S1473-3099(16)30270-5
-
Cao-Lormeau VM, Blake A, Mons S, Lastère S, Roche C, Vanhomwegen J, Dub T, Baudouin L, Teissier A, Larre P, Vial AL, Decam C, Choumet V, Halstead SK, Willison HJ, Musset L, Manuguerra JC, Despres P, Fournier E, Mallet HP, Musso D, Fontanet A, Neil J, Ghawché F, 2016: Guillain-barré syndrome outbreak associated with zika virus infection in French polynesia: a case-control study[J]. Lancet, 387, 1531-1539. doi: 10.1016/S0140-6736(16)00562-6
-
da Silva S, Oliveira Silva Martins D, Jardim ACG, 2018: A review of the ongoing research on zika virus treatment[J]. Viruses, 10, 255-. doi: 10.3390/v10050255
-
Dai L, Song J, Lu X, Deng YQ, Musyoki AM, Cheng H, Zhang Y, Yuan Y, Song H, Haywood J, Xiao H, Yan J, Shi Y, Qin CF, Qi J, Gao GF, 2016: Structures of the zika virus envelope protein and its complex with a flavivirus broadly protective antibody[J]. Cell Host Microbe, 19, 696-704. doi: 10.1016/j.chom.2016.04.013
-
Dai S, Zhang T, Zhang Y, Wang H, Deng F, 2018: Zika virus baculovirus-expressed virus-like particles induce neutralizing antibodies in mice[J]. Virol Sin, 33, 213-226. doi: 10.1007/s12250-018-0030-5
-
Dávila-Castrodad NM, Reyes-Bou Z, Correa-Rivas M, Pérez-Berenguer JL, Di-Pasquale L, García-García I, 2018: First autopsy of a newborn with congenital zika syndrome in puerto rico[J]. Proc R Health Sci J, 37, S81-S84.
-
de Araújo TVB, Ximenes RAA, Miranda-Filho DB, Souza WV, Montarroyos UR, de Melo APL, Valongueiro S, de Albuquerque M, Braga C, Filho SPB, Cordeiro MT, Vazquez E, Cruz D, Henriques CMP, Bezerra LCA, Castanha P, Dhalia R, Marques-Júnior ETA, Martelli CMT, Rodrigues LC, 2018: Association between microcephaly, zika virus infection, and other risk factors in brazil: final report of a case-control study[J]. Lancet Infect Dis, 18, 328-336. doi: 10.1016/S1473-3099(17)30727-2
-
Deng C, Liu S, Zhang Q, Xu M, Zhang H, Gu D, Shi L, He J, Xiao G, Zhang B, 2016: Isolation and characterization of zika virus imported to china using c6/36 mosquito cells[J]. Virol Sin, 31, 176-179. doi: 10.1007/s12250-016-3778-5
-
D'Ortenzio E, Matheron S, Yazdanpanah Y, de Lamballerie X, Hubert B, Piorkowski G, Maquart M, Descamps D, Damond F, Leparc-Goffart I, 2016: Evidence of sexual transmission of zika virus[J]. N Engl J Med, 374, 2195-2198. doi: 10.1056/NEJMc1604449
-
Dowall SD, Graham VA, Rayner E, Atkinson B, Hall G, Watson RJ, Bosworth A, Bonney LC, Kitchen S, Hewson R, 2016: A susceptible mouse model for zika virus infection[J]. PLoS Negl Trop Dis, 10, e0004658-. doi: 10.1371/journal.pntd.0004658
-
Durbin A, Wilder-Smith A, 2017: An update on zika vaccine developments[J]. Expert Rev Vaccines, 16, 781-787. doi: 10.1080/14760584.2017.1345309
-
Enfissi A, Codrington J, Roosblad J, Kazanji M, Rousset D, 2016: Zika virus genome from the americas[J]. Lancet, 387, 227-228. doi: 10.1016/S0140-6736(16)00003-9
-
Garg H, Mehmetoglu-Gurbuz T, Joshi A, 2018: Recent advances in zika virus vaccines[J]. Viruses, 10, 631-. doi: 10.3390/v10110631
-
Ghaffar KA, Ng LFP, Renia L, 2018: Fast tracks and roadblocks for zika vaccines[J]. Vaccines (Basel), 6, 77-. doi: 10.3390/vaccines6040077
-
Govero J, Esakky P, Scheaffer SM, Fernandez E, Drury A, Platt DJ, Gorman MJ, Richner JM, Caine EA, Salazar V, Moley KH, Diamond MS, 2016: Zika virus infection damages the testes in mice[J]. Nature, 540, 438-442. doi: 10.1038/nature20556
-
Gupta K, Tölzer C, Sari-Ak D, Fitzgerald DJ, Schaffitzel C, Berger I, 2019: Multibac: baculovirus-mediated multigene DNA cargo delivery in insect and mammalian cells[J]. Viruses, 11, 198-. doi: 10.3390/v11030198
-
Kaname Y, Tani H, Kataoka C, Shiokawa M, Taguwa S, Abe T, Moriishi K, Kinoshita T, Matsuura Y, 2010: Acquisition of complement resistance through incorporation of cd55/decay-accelerating factor into viral particles bearing baculovirus gp64[J]. J Virol, 84, 3210-3219. doi: 10.1128/JVI.02519-09
-
Kost TA, Condreay JP, Jarvis DL, 2005: Baculovirus as versatile vectors for protein expression in insect and mammalian cells[J]. Nat Biotechnol, 23, 567-575. doi: 10.1038/nbt1095
-
Kostyuchenko VA, Lim EX, Zhang S, Fibriansah G, Ng TS, Ooi JS, Shi J, Lok SM, 2016: Structure of the thermally stable zika virus[J]. Nature, 533, 425-428. doi: 10.1038/nature17994
-
Lazear HM, Govero J, Smith AM, Platt DJ, Fernandez E, Miner JJ, Diamond MS, 2016: A mouse model of zika virus pathogenesis[J]. Cell Host Microbe, 19, 720-730. doi: 10.1016/j.chom.2016.03.010
-
Lecouturier V, Bernard MC, Berry C, Carayol S, Richier E, Boudet F, Heinrichs J, 2019: Immunogenicity and protection conferred by an optimized purified inactivated zika vaccine in mice[J]. Vaccine, 37, 2679-2686. doi: 10.1016/j.vaccine.2019.04.013
-
Li P, Ke X, Wang T, Tan Z, Luo D, Miao Y, Sun J, Zhang Y, Liu Y, Hu Q, Xu F, Wang H, Zheng Z, 2018: Zika virus attenuation by codon pair deoptimization induces sterilizing immunity in mouse models[J]. J Virol, 92, e00701-18.
-
Lin HH, Yip BS, Huang LM, Wu SC, 2018: Zika virus structural biology and progress in vaccine development[J]. Biotechnol Adv, 36, 47-53. doi: 10.1016/j.biotechadv.2017.09.004
-
Lindley KM, Su JL, Hodges PK, Wisely GB, Bledsoe RK, Condreay JP, Winegar DA, Hutchins JT, Kost TA, 2000: Production of monoclonal antibodies using recombinant baculovirus displaying gp64-fusion proteins[J]. J Immunol Methods, 234, 123-135. doi: 10.1016/S0022-1759(99)00133-7
-
Ma W, Li S, Ma S, Jia L, Zhang F, Zhang Y, Zhang J, Wong G, Zhang S, Lu X, Liu M, Yan J, Li W, Qin C, Han D, Qin C, Wang N, Li X, Gao GF, 2017: Zika virus causes testis damage and leads to male infertility in mice[J]. Cell, 168, 542-.
-
Martines RB, Bhatnagar J, de Oliveira Ramos AM, Davi HP, Iglezias SD, Kanamura CT, Keating MK, Hale G, Silva-Flannery L, Muehlenbachs A, Ritter J, Gary J, Rollin D, Goldsmith CS, Reagan-Steiner S, Ermias Y, Suzuki T, Luz KG, de Oliveira WK, Lanciotti R, Lambert A, Shieh WJ, Zaki SR, 2016: Pathology of congenital zika syndrome in brazil: a case series[J]. Lancet, 388, 898-904. doi: 10.1016/S0140-6736(16)30883-2
-
Martinez-Sobrido L, Almazán F, 2019: New advances on zika virus research[J]. Viruses, 11, 258-. doi: 10.3390/v11030258
-
Mlakar J, Korva M, Tul N, Popović M, Poljšak-Prijatelj M, Mraz J, Kolenc M, Resman Rus K, Vesnaver Vipotnik T, Fabjan Vodušek V, Vizjak A, Pižem J, Petrovec M, Avšič Županc T, 2016: Zika virus associated with microcephaly[J]. N Engl J Med, 374, 951-958. doi: 10.1056/NEJMoa1600651
-
Morrison TE, Diamond MS, 2017: Animal models of zika virus infection, pathogenesis, and immunity[J]. J Virol, 91, e00009-17.
-
Musso D, Gubler DJ, 2016: Zika virus[J]. Clin Microbiol Rev, 29, 487-524. doi: 10.1128/CMR.00072-15
-
Ono C, Okamoto T, Abe T, Matsuura Y, 2018: Baculovirus as a tool for gene delivery and gene therapy[J]. Viruses, 10, 510-. doi: 10.3390/v10090510
-
Pardi N, Hogan MJ, Pelc RS, Muramatsu H, Andersen H, DeMaso CR, Dowd KA, Sutherland LL, Scearce RM, Parks R, Wagner W, Granados A, Greenhouse J, Walker M, Willis E, Yu JS, McGee CE, Sempowski GD, Mui BL, Tam YK, Huang YJ, Vanlandingham D, Holmes VM, Balachandran H, Sahu S, Lifton M, Higgs S, Hensley SE, Madden TD, Hope MJ, Karikó K, Santra S, Graham BS, Lewis MG, Pierson TC, Haynes BF, Weissman D, 2017: Zika virus protection by a single low-dose nucleoside-modified mrna vaccination[J]. Nature, 543, 248-251. doi: 10.1038/nature21428
-
Peng R, Zhang S, Cui Y, Shi Y, Gao GF, Qi J, 2017: Structures of human-infecting thogotovirus fusogens support a common ancestor with insect baculovirus[J]. Proc Natl Acad Sci USA, 114, E8905-e8912. doi: 10.1073/pnas.1706125114
-
Premanand B, Zhong Wee P, Prabakaran M, 2018: Baculovirus surface display of immunogenic proteins for vaccine development[J]. Viruses, 10, 298-. doi: 10.3390/v10060298
-
Qu P, Zhang W, Li D, Zhang C, Liu Q, Zhang X, Wang X, Dai W, Xu Y, Leng Q, Zhong J, Jin X, Huang Z, 2018: Insect cell-produced recombinant protein subunit vaccines protect against zika virus infection[J]. Antiviral Res, 154, 97-103. doi: 10.1016/j.antiviral.2018.04.010
-
Richner JM, Himansu S, Dowd KA, Butler SL, Salazar V, Fox JM, Julander JG, Tang WW, Shresta S, Pierson TC, Ciaramella G, Diamond MS, 2017: Modified mrna vaccines protect against zika virus infection[J]. Cell, 168, 1114-1125.e1110. doi: 10.1016/j.cell.2017.02.017
-
Rossi SL, Tesh RB, Azar SR, Muruato AE, Hanley KA, Auguste AJ, Langsjoen RM, Paessler S, Vasilakis N, Weaver SC, 2016: Characterization of a novel murine model to study zika virus[J]. Am J Trop Med Hyg, 94, 1362-1369. doi: 10.4269/ajtmh.16-0111
-
Saiz JC, Oya NJ, Blázquez AB, Escribano-Romero E, Martín-Acebes MA, 2018: Host-directed antivirals: a realistic alternative to fight zika virus[J]. Viruses, 10, 453-. doi: 10.3390/v10090453
-
Saxena M, Van TTH, Baird FJ, Coloe PJ, Smooker PM, 2013: Pre-existing immunity against vaccine vectors-friend or foe?[J]. Microbiology, 159, 1-11. doi: 10.1099/mic.0.049601-0
-
Shan C, Muruato AE, Nunes BTD, Luo H, Xie X, Medeiros DBA, Wakamiya M, Tesh RB, Barrett AD, Wang T, Weaver SC, Vasconcelos PFC, Rossi SL, Shi PY, 2017: A live-attenuated zika virus vaccine candidate induces sterilizing immunity in mouse models[J]. Nat Med, 23, 763-767. doi: 10.1038/nm.4322
-
Singh RK, Dhama K, Khandia R, Munjal A, Karthik K, Tiwari R, Chakraborty S, Malik YS, Bueno-Marí R, 2018: Prevention and control strategies to counter zika virus, a special focus on intervention approaches against vector mosquitoes-current updates[J]. Front Microbiol, 9, 87-. doi: 10.3389/fmicb.2018.00087
-
Wang B, Yang C, Tekes G, Mueller S, Paul A, Whelan SP, Wimmer E, 2015: Recoding of the vesicular stomatitis virus l gene by computer-aided design provides a live, attenuated vaccine candidate[J]. mBio, 6, e00237-15.
-
Weger-Lucarelli J, Duggal NK, Bullard-Feibelman K, Veselinovic M, Romo H, Nguyen C, Rückert C, Brault AC, Bowen RA, Stenglein M, Geiss BJ, Ebel GD, 2017: Development and characterization of recombinant virus generated from a new world zika virus infectious clone[J]. J Virol, 91, e01765-16.
-
White MK, Wollebo HS, David Beckham J, Tyler KL, Khalili K, 2016: Zika virus: an emergent neuropathological agent[J]. Ann Neurol, 80, 479-489. doi: 10.1002/ana.24748
-
Wikan N, Smith DR, 2016: Zika virus: history of a newly emerging arbovirus[J]. Lancet Infect Dis, 16, e119-e126. doi: 10.1016/S1473-3099(16)30010-X
-
Wu Q, Fang L, Wu X, Li B, Luo R, Yu Z, Jin M, Chen H, Xiao S, 2009: A pseudotype baculovirus-mediated vaccine confers protective immunity against lethal challenge with h5n1 avian influenza virus in mice and chickens[J]. Mol Immunol, 46, 2210-2217. doi: 10.1016/j.molimm.2009.04.017
-
Xu XG, Wang ZS, Zhang Q, Li ZC, Zhao HN, Li W, Tong DW, Liu HJ, 2011: Baculovirus surface display of e envelope glycoprotein of japanese encephalitis virus and its immunogenicity of the displayed proteins in mouse and swine models[J]. Vaccine, 29, 636-643. doi: 10.1016/j.vaccine.2010.11.045
-
Yamaji H, 2014: Suitability and perspectives on using recombinant insect cells for the production of virus-like particles[J]. Appl Microbiol Biotechnol, 98, 1963-1970. doi: 10.1007/s00253-013-5474-9
-
Yang C, Gong R, de Val N, 2019: Development of neutralizing antibodies against zika virus based on its envelope protein structure[J]. Virol Sin, 34, 168-174. doi: 10.1007/s12250-019-00093-5
-
Zhao H, Fernandez E, Dowd KA, Speer SD, Platt DJ, Gorman MJ, Govero J, Nelson CA, Pierson TC, Diamond MS, Fremont DH, 2016: Structural basis of zika virus-specific antibody protection[J]. Cell, 166, 1016-1027. doi: 10.1016/j.cell.2016.07.020
-
Zheng H, Wang X, Ren F, Zou S, Feng M, Xu L, Yao L, Sun J, 2018: Construction of a highly efficient display system for baculovirus and its application on multigene co-display[J]. Mol Genet Genomics, 293, 1265-1277. doi: 10.1007/s00438-018-1459-9